Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies

Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies

Edward Meier,1 Abhijit Narvekar,2 Ganesh R Iyer,2 Harvey B DuBiner,3 Apinya Vutikullird,4 David Wirta,5 Kenneth Sall61Apex Eye, Mason, OH, 2Alcon Research Ltd., Fort Worth, TX, 3Clayton Eye Center, Morrow, GA, 4WCCT Global, Cypress, 5Eye Research Foundation, Newport Beach, 6Sall Eye Researc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Meier E, Narvekar A, Iyer GR, DuBiner HB, Vutikullird A, Wirta D, Sall K
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Ocular allergy
allergic conjunctivitis
olopatadine
pharmacokinetics
safety
Ophthalmology
RE1-994
Acceso en línea:https://doaj.org/article/f5dce38dc0a34beb94abeb38f871ad08
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/f5dce38dc0a34beb94abeb38f871ad08

Ejemplares similares